Christopher Joy
Overview
Explore the profile of Christopher Joy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nasr M, Aldous A, Daniels J, Joy C, Capozzi E, Yang M, et al.
PLoS One
. 2024 Jul;
19(7):e0306237.
PMID: 39008499
Adolescent girls bear a disproportionate burden of both the HIV epidemic and unintended pregnancies; yet important questions remain unanswered regarding the effects of hormonal contraceptives on the vaginal immune microenvironment,...
2.
Vargas A, Joy C, Maclean F, Bonar F, Wong D, Gill A, et al.
J Clin Pathol
. 2023 Dec;
77(4):251-254.
PMID: 38053271
Angiomatoid fibrous histiocytoma (AFH) is a soft tissue tumour of intermediate (rarely metastasising) malignant potential, which harbours gene fusions. These tumours can express anaplastic lymphoma kinase (ALK) in the absence...
3.
McKeague S, ORourke K, Fanning S, Joy C, Throp D, Adams R, et al.
Am J Clin Pathol
. 2023 Oct;
161(2):197-205.
PMID: 37855739
Objectives: Myeloid/lymphoid neoplasms with FGFR1 rearrangement are a rare group of neoplasms that share features of eosinophilia and lineage promiscuity. First, we described a challenging case of acute leukemia with...
4.
Vargas A, Barton N, Jones V, Joy C, Harraway J, Cheah A, et al.
Pathology
. 2023 Jul;
55(6):879-883.
PMID: 37507332
No abstract available.
5.
Galea L, Hildebrand M, Witkowski T, Joy C, McEvoy C, Hanegbi U, et al.
Virchows Arch
. 2022 Nov;
482(3):625-633.
PMID: 36370168
ALK-rearranged renal cell carcinoma (ALK-RCC) is a very rare novel molecularly defined entity in the recently published fifth edition of the World Health Organization classification of tumours. We describe a...
6.
Petrides G, Joy C, Dolk O, Hubert Low T, Lovell N, Eviston T
Plast Reconstr Surg
. 2022 Jul;
150(3):639e-643e.
PMID: 35791287
Existing automated objective grading systems either fail to consider the face's complex three-dimensional morphology or have poor feasibility and usability. Consumer-based red, green, and blue depth sensors or smartphone integrated...
7.
Galea L, Hildebrand M, Boys A, Joy C, Chee J, White G
Pathology
. 2022 Jun;
55(1):143-146.
PMID: 35644639
No abstract available.
8.
Vargas A, Grimison P, Joy C, Garrone B, Bonar F, Ghahan R, et al.
Int J Surg Pathol
. 2021 Dec;
30(4):462-465.
PMID: 34955058
MYC over-expression by immunohistochemistry (IHC) is utilised in routine pathology practice as a surrogate marker for amplification, which plays a key oncogenic role in post-irradiation and chronic lymphedema-associated angiosarcoma. We...
9.
Vargas A, Joy C, Cheah A, Jones M, Bonar F, Brookwell R, et al.
Histopathology
. 2021 Sep;
80(2):369-380.
PMID: 34523152
Aims: Amplification of the murine double minute-2 (MDM2) gene, which is usually detected with fluorescence in-situ hybridisation (FISH), is the key driving event for atypical lipomatous tumours (ALTs)/well-differentiated liposarcomas (WDLs)....
10.
Yousef S, Joy C, Velaiutham S, Maclean F, Harraway J, Gill A, et al.
Pathology
. 2021 Aug;
54(3):371-374.
PMID: 34420795
No abstract available.